![Debjani Singh](/sites/default/files/styles/featured_square_large/public/2024-08/2024-P12408.jpg?h=8f9cfe54&itok=bP5F6U4Y)
Filter News
Area of Research
- Biological Systems (1)
- Biology and Environment (46)
- Clean Energy (14)
- Computational Biology (1)
- Fusion and Fission (6)
- Isotopes (3)
- Materials (18)
- Materials for Computing (1)
- National Security (3)
- Neutron Science (7)
- Nuclear Science and Technology (5)
- Quantum information Science (1)
- Supercomputing (25)
News Type
News Topics
- (-) Advanced Reactors (9)
- (-) Bioenergy (52)
- (-) Biomedical (31)
- (-) Biotechnology (13)
- (-) Exascale Computing (28)
- (-) Mercury (7)
- (-) Physics (36)
- 3-D Printing/Advanced Manufacturing (46)
- Artificial Intelligence (51)
- Big Data (32)
- Biology (61)
- Buildings (26)
- Chemical Sciences (29)
- Clean Water (16)
- Climate Change (56)
- Composites (9)
- Computer Science (92)
- Coronavirus (18)
- Critical Materials (6)
- Cybersecurity (14)
- Decarbonization (50)
- Education (1)
- Emergency (2)
- Energy Storage (36)
- Environment (111)
- Fossil Energy (4)
- Frontier (27)
- Fusion (33)
- Grid (28)
- High-Performance Computing (47)
- Hydropower (5)
- Isotopes (31)
- ITER (2)
- Machine Learning (23)
- Materials (45)
- Materials Science (56)
- Mathematics (7)
- Microelectronics (3)
- Microscopy (23)
- Molten Salt (1)
- Nanotechnology (20)
- National Security (48)
- Net Zero (8)
- Neutron Science (52)
- Nuclear Energy (61)
- Partnerships (19)
- Polymers (11)
- Quantum Computing (22)
- Quantum Science (32)
- Renewable Energy (1)
- Security (13)
- Simulation (33)
- Software (1)
- Space Exploration (12)
- Statistics (1)
- Summit (31)
- Sustainable Energy (51)
- Transformational Challenge Reactor (3)
- Transportation (32)
Media Contacts
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Nesaraja split her effort between nuclear data evaluation and experimentation at ORNL’s now-closed Holifield Radioactive Ion Beam Facility. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/2021-P00917_0.jpg?h=8f9cfe54&itok=8oV5bH2S)
Nuclear physicist Caroline Nesaraja of the Department of Energy’s Oak Ridge National Laboratory evaluates nuclear data vital to applied and basic sciences.
![The researchers embedded a programmable model into a D-Wave quantum computer chip. Credit: D-Wave](/sites/default/files/styles/list_page_thumbnail/public/2021-02/P5-o5czF_0.jpg?h=b69e0e0e&itok=wCU6WIp_)
Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.
![ORNL’s Marcel Demarteau inspects experiments along Neutrino Alley at the Spallation Neutron Source, which makes neutrinos as a byproduct. Credit: Genevieve Martin/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-12/2020-P15166_0.jpg?h=c6980913&itok=GkpktZzV)
Marcel Demarteau is director of the Physics Division at the Department of Energy’s Oak Ridge National Laboratory. For topics from nuclear structure to astrophysics, he shapes ORNL’s physics research agenda.
![A Co-Optima research team led by Oak Ridge National Laboratory’s Jim Szybist in collaboration with Argonne, Sandia and the National Renewable Energy Laboratory, created a merit function tool that evaluates six fuel properties and their impact on engine performance, giving the scientific community a guide to quickly evaluate biofuels. Credit: ORNL/U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-12/2017-P08539-2_0.jpg?h=b6236d98&itok=h0OT2BqC)
As ORNL’s fuel properties technical lead for the U.S. Department of Energy’s Co-Optimization of Fuel and Engines, or Co-Optima, initiative, Jim Szybist has been on a quest for the past few years to identify the most significant indicators for predicting how a fuel will perform in engines designed for light-duty vehicles such as passenger cars and pickup trucks.
![Researchers Adam Guss and Melissa Tumen-Velasquez work with microbes to understand how the organisms consume plastics and break them into chemical components that can be used to make higher-value products.](/sites/default/files/styles/list_page_thumbnail/public/2020-11/2020-P17629.jpg?h=98541007&itok=54ubVna4)
From soda bottles to car bumpers to piping, electronics, and packaging, plastics have become a ubiquitous part of our lives.
![Frontier supercomputer](/sites/default/files/styles/list_page_thumbnail/public/2023-01/frontier_0.jpg?h=a1e1a043&itok=J3IM_Xeh)
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
![coronavirus](/sites/default/files/styles/list_page_thumbnail/public/2020-11/coronavirus_top10%20%28002%29.png?h=997b30da&itok=7I6TjG_l)
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
![Sandra Davern performs cell based assays to evaluate cell death and DNA damage in response to radiation in order to gain a better understanding of how radioisotope nanoparticles affect the human body.](/sites/default/files/styles/list_page_thumbnail/public/2020-10/2020-P15712.jpg?h=036a71b7&itok=6cpxN4v2)
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.